A new report published by the ABPI and Vermilion Life Sciences this week identifies a number of stakeholder issues and proposed actions for the UK in reengineering medicines development.Read more
The ABPI and the UK BioIndustry Association (BIA) have welcomed the Government’s decision to fund a project to develop new digital design and manufacturing processes for medicines.Read more
The Association of the British Pharmaceutical Industry has warmly welcomed the Chancellor of the Exchequer’s announcement that the Government will review the Entrepreneur’s Relief (ER) scheme which has the potential to boost the UK innovation landscape for spin-out pharmaceutical companies.Read more
In the lead up to our Annual Conference 2015, Stuart Dollow, Chief Executive of Vermilion Life Sciences and one of our conference speakers, explains how our healthcare challenges require a different approach to benefit from new tools and technologies to deliver affordable public health improvements.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.